Business Opportunities

Intas Pharma ties up with US company

Ahmedabad-based Intas Pharmaceuticals Ltd (Intas) has entered into a strategic partnership with US biotechnology company Amarillo Biosciences, Inc (ABI), whereby Intas will sponsor clinical trials of ABI’s orally administered interferon-alpha lozenges for influenza, which could also be used in combating the H1N1 virus. Sensex ends up 35pts According to recent reports, the death rate in India from H1N1 infection is 3.1 per cent and the virus continues to circulate in the country.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Copenhagen accord has inbuilt hazards: Ramesh
The Copenhagen accord on climate change was a partial success for India but it has certain "inbuilt hazards" of which the developing countries have to be wary, Environment Minister Jairam Ramesh said here.
Popular Articles
Modern furniture stores in nyc

Symbol for rupee in final lap
Panel shortlists five candidates, decision on winning entry in January.

Markets succumb to weak Asian cues
The markets extended the previous day"s losses, mirroring the weakness in the US and across Asia. The Sensex ended at 16,719, weaker by 174 points and the Nifty closed below the psychological mark of 5k at 4,987, lower by 54 points. Realty, energy and bank stocks were the major draggers.

© Copyright 2009